Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Other Accumulated Expenses (2020 - 2023)

Terns Pharmaceuticals (TERN) has disclosed Other Accumulated Expenses for 4 consecutive years, with $392000.0 as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Other Accumulated Expenses rose 27.27% year-over-year to $392000.0, compared with a TTM value of $392000.0 through Sep 2023, up 27.27%, and an annual FY2022 reading of $185000.0, down 48.32% over the prior year.
  • Other Accumulated Expenses was $392000.0 for Q3 2023 at Terns Pharmaceuticals, up from $280000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $392000.0 in Q3 2023 and bottomed at $83000.0 in Q1 2021.
  • Average Other Accumulated Expenses over 4 years is $230416.7, with a median of $228000.0 recorded in 2022.
  • Peak annual rise in Other Accumulated Expenses hit 271.08% in 2022, while the deepest fall reached 48.32% in 2022.
  • Year by year, Other Accumulated Expenses stood at $162000.0 in 2020, then surged by 120.99% to $358000.0 in 2021, then crashed by 48.32% to $185000.0 in 2022, then soared by 111.89% to $392000.0 in 2023.
  • Business Quant data shows Other Accumulated Expenses for TERN at $392000.0 in Q3 2023, $280000.0 in Q2 2023, and $363000.0 in Q1 2023.